Gadalquiver, John .
HRN: 21-47-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
METRONIDAZOLE 500MG (TAB)
06/27/2022
07/03/2022
PO
500mg
TID
AGE
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes